EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Effect of acute hyperglycemia on basal, secretin and secretin + cholecystokinin stimulated exocrine pancreatic secretion in humans



Effect of acute hyperglycemia on basal, secretin and secretin + cholecystokinin stimulated exocrine pancreatic secretion in humans



Life Sciences 64(8): 617-626



Pancreatico-biliary secretion is reduced during acute hyperglycemia. We investigated whether alterations in pancreatico-biliary flow or volume output are responsible for the observed reduction in duodenal output of pancreatic enzymes and bilirubin during hyperglycemia. Eight healthy subjects were studied on two occasions during normoglycemia and hyperglycemia (15 mmol/l). Pancreatico-biliary output was measured by aspiration using a recovery marker under basal conditions (60 min), during secretin infusion (0.1 CU/kg.h) for 60 min and during secretin + CCK (0.5 IDU/kg.h) infusion for 60 min. Secretin was infused to stimulate pancreatico-biliary flow and volume output. Secretin significantly (P < 0.005–P < 0.05) increased volume and bicarbonate output and CCK significantly (P < 0.01) increased the output of bilirubin, pancreatic enzymes, bicarbonate and volume, both during normoglycemia and hyperglycemia. During hyperglycemia basal, secretin stimulated and secretin + CCK stimulated total pancreatico-biliary output were significantly (P < 0.005–P < 0.05) reduced compared to normoglycemia. The incremental outputs, however, were not significantly different between hyper- and normoglycemia. Pancreatic volume output was significantly (P < 0.05) reduced during hyperglycemia compared to normoglycemia under basal conditions (31 ± 16 ml/h versus 132 ± 33 ml/h) during secretin infusion (130 ± 17 ml/h versus 200 ± 34 ml/h) and during secretin + CCK infusion (370 ± 39 ml/h versus 573 ± 82 ml/h). Plasma PP levels were significantly (P < 0.05) reduced during hyperglycemia. It is concluded that 1) hyperglycemia significantly reduces basal pancreatico-biliary output 2) the incremental pancreaticobiliary output in response to secretin or secretin + CCK infusion is not significantly affected during hyperglycemia, 3) a reduction in volume output contributes to the inhibitory effect of hyperglycemia on pancreatico-biliary secretion, 4) hyperglycemia reduces PP secretion suggesting vagal-cholinergic inhibition of pancreatico-biliary secretion and volume during hyperglycemia.

(PDF same-day service: $19.90)

Accession: 017870516

Download citation: RISBibTeXText

PMID: 10069525

DOI: 10.1016/s0024-3205(98)00604-3



Related references

Effect of acute hyperglycemia on basal, secretin and secretin plus cholecystokinin stimulated exocrine pancreatic secretion in humans. Life Sciences 64(8): 617-626, Jan 15, 1999

Effect of acute hyperglycemia on basal and cholecystokinin stimulated exocrine pancreatic secretion in humans. Life Sciences 60(24): 2183-2190, 1997

Glucagon inhibition of secretin and combined secretin and cholecystokinin stimulated pancreatic exocrine secretion in health and disease. Digestion 17(1): 11-17, 1978

Effect of secretin on basal and CCK stimulated pancreatic secretion during acute hyperglycemia. Digestion 58(SUPPL 2): 46, 1997

The effect of secretin on the exocrine and endocrine pancreas 4. plasma insulin glucagon and secretin concentrations and pancreatic exocrine secretion in response to a bolus injection of synthetic secretin in the rat. Folia Endocrinologica Japonica 56(3): 199-207, 1980

Potentiating effect of secretin on cholecystokinin-stimulated exocrine pancreatic secretion in rats. Nihon Shokakibyo Gakkai Zasshi 86(10): 2425-2433, 1989

The effect of secretin on exocrine and endocrine pancreas. Part I: plasma secretin concentration and pancreatic exocrine secretion after intravenous secretin or intraduodenal HCl and 1-phenyl-1-hydroxy-n-pentane administration. Nihon Naibunpi Gakkai Zasshi 54(10): 1116-1124, 1978

The effect of secretin on the exocrine and endocrine pancreas. Part 4: Plasma insulin, glucagon and secretin concentrations and pancreatic exocrine secretion in response to a bolus injection of synthetic secretin in the rat. Nihon Naibunpi Gakkai Zasshi 56(3): 199-207, 1980

Atropine abolishes the potentiation effect of secretin and cholecystokinin-octapeptide on exocrine pancreatic secretion in humans. Pancreas 3(1): 99-103, 1988

The effect of secretin on exocrine and endocrine pancreas part 1 plasma secretin concentration and pancreatic exocrine secretion after intra venous secretin or intra duodenal hydro chloric acid and 1 phenyl 1 hydroxy n pentane administration. Folia Endocrinologica Japonica 54(10): 1116-1124, 1978

Effects of pancreatic polypeptide on the pancreatic exocrine secretion stimulated by secretin and cholecystokinin in the conscious pig. Regulatory Peptides 24(1): 55-66, 1989

Potentiation effect of cholecystokinin-octapeptide on pancreatic bicarbonate secretion stimulated by a physiologic dose of secretin in humans. Gastroenterology 85(1): 40-45, 1983

Role of histamine receptors in rabbit pancreatic exocrine secretion stimulated by cholecystokinin and secretin. Experimental Physiology 75(5): 657-667, 1990

Effects of substance P on pancreatic exocrine secretion stimulated by secretin, dopamine and cholecystokinin in dogs. Clinical and Experimental Pharmacology & Physiology 13(9): 663-670, 1986

Potentiation of cholecystokinin and secretin-induced pancreatic exocrine secretion by endogenous insulin in humans. Pancreas 18(4): 410-414, 1999